During the past decade, Oakwood Healthcare, Inc. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oakwood Healthcare, Inc." #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Oakwood Healthcare, Inc." are "Breast Cancer" (1 trials), "Leukemia, Myeloid, Acute" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Primary Myelofibrosis" (1 trials). Many other conditions were trialed in "Oakwood Healthcare, Inc." in a lesser frequency.

Most popular intervention types in "Oakwood Healthcare, Inc." are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (1 trials), "Everolimus" (1 trials), "Fulvestrant" (1 trials), "Placebo - Anastrozole" (1 trials) and "Placebo - Everolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oakwood Healthcare, Inc." are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Oakwood Healthcare, Inc.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oakwood Healthcare, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oakwood Healthcare, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".